Sarepta Therapeutics, Inc. Stock Sao Paulo
Equities
S1RP34
BRS1RPBDR005
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.49 BRL | -0.07% |
|
-6.22% | +80.71% |
Jun. 26 | Monetary policy is getting even more confusing | ![]() |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
Sales 2024 * | 2.03B 11.1B | Sales 2025 * | 3.23B 17.67B | Capitalization | 14.32B 78.25B |
---|---|---|---|---|---|
Net income 2024 * | 338M 1.85B | Net income 2025 * | 1.08B 5.9B | EV / Sales 2024 * | 6.49 x |
Net cash position 2024 * | 1.12B 6.14B | Net cash position 2025 * | 2.79B 15.24B | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
40
x | P/E ratio 2025 * |
12.5
x | Employees | 1,314 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.03% |
Latest transcript on Sarepta Therapeutics, Inc.
1 day | -0.07% | ||
1 week | -6.22% | ||
Current month | -6.55% | ||
1 month | +25.39% | ||
3 months | +28.89% | ||
6 months | +76.93% | ||
Current year | +80.71% |
![Extreme 41.49](/images/extremecours_fleche.png)
![Extreme 32.37](/images/extremecours_fleche.png)
![Extreme 23.42](/images/extremecours_fleche.png)
![Extreme 18.89](/images/extremecours_fleche.png)
![Extreme 15.94](/images/extremecours_fleche.png)
![Extreme 15.94](/images/extremecours_fleche.png)
![Extreme 15.94](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 17-06-25 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 14-12-31 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 17-06-25 |
M. Wilsey
CHM | Chairman | 71 | 09-03-30 |
Richard Barry
BRD | Director/Board Member | 65 | 15-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-08 | 41.49 | -0.07% | 350 |
24-07-05 | 41.52 | -2.81% | 3,040 |
24-07-03 | 42.72 | -3.26% | 571 |
24-07-02 | 44.16 | -0.18% | 1,513 |
Delayed Quote Sao Paulo, July 08, 2024 at 02:17 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.43% | 124B | |
+19.81% | 114B | |
-23.74% | 19.42B | |
-18.19% | 16.2B | |
-19.97% | 15.31B | |
-49.33% | 14.19B | |
+7.95% | 14.31B | |
+126.04% | 11.29B | |
+156.83% | 9.71B |
- Stock Market
- Equities
- SRPT Stock
- S1RP34 Stock